F410 10mg*10vials

FOXO4-DRI F410 10mg*10vials

FOXO4-DRI is a novel synthetic peptide designed to selectively target and eliminate senescent cells, also known as "zombie cells" that accumulate with age and contribute to tissue dysfunction. It represents a cutting-edge research peptide in senolytic and anti-aging studies.

The 10mg single-vial specification is the standard concentration, ideal for dose-response studies, extended senolytic mechanism experiments, and researchers conducting foundational cellular aging research. This concentration offers reliable dosing in experimental design, allowing researchers to study senescence pathways across a range of experimental protocols.

Through its targeted FOXO4-p53 interaction pathway, FOXO4-DRI supports research into senescent cell clearance, tissue rejuvenation, and healthy aging. It is designed to study how removing dysfunctional aging cells from tissues can restore cellular function, reduce age-related inflammation, and support tissue regeneration.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Each batch undergoes rigorous purity testing, with a certificate of analysis provided.

10 vials per pack, suitable for specialized laboratory research and cellular aging mechanism studies.